Search
Neuropsychiatric EEG-Based Assessment Aid (NEBA)
Indications:
- assessment of attention-deficit/hyperactivity disorder (ADHD) in children & adolescents 6-17 years of age [1]
Procedure:
- 15-20-minute non-invasive test that calculates the ratio of EEG theta wave & EEG beta wave frequencies
Clinical significance:
- theta wave/beta wave ratio is higher in children & adolescents with ADHD than in children without
Notes:
- device/procedure not without skeptics
General
electroencephalography (EEG)
device (medical device)
References
- FDA News Release: July 15, 2013
FDA permits marketing of first brain wave test to help assess
children and teens for ADHD.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm360811.htm